Ansøgningsnr. og dato | 17716763.2 (espacenet) (Federated) (European Patent Register), 20170331 | Patent/reg.nr. og dato | DK/EP 3436446, 20230607 | Tilgængelighedsdato | 20190206 | Prioritetsnr. og dato | US 201662316043 P, 20160331 | EP publ. nr. og dato |
EP 3436446 20190206 | Løbedag | | Ansøger/indehaver | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | Ansøgers ref. nr. | | Opfinder | BEAR, Brian, 50 Northern Avenue
Boston MA 02210, US, CLEMENS, Jeremy, 50 Northern Avenue
Boston MA 02210, US, CLEVELAND, Thomas, 50 Northern Avenue
Boston MA 02210, US, COON, Timothy, Richard, 50 Northern Avenue
Boston MA 02210, US, GROOTENHUIS, Peter, Diederik Jan, 50 Northern Avenue
Boston MA 02210, US, FRIEMAN, Bryan, A., 50 Northern Avenue
Boston MA 02210, US, HADIDA RUAH, Sara S., 50 Northern Avenue
Boston MA 02210, US, KHATUYA, Haripada, 50 Northern Avenue
Boston MA 02210, US, KRENITSKY, Paul, J., 50 Northern Avenue
Boston MA 02210, US, MILLER, Mark, Thomas, 50 Northern Avenue
Boston MA 02210, US, SILINA, Alina, 50 Northern Avenue
Boston MA 02210, US, UY, Johnny, 50 Northern Avenue
Boston MA 02210, US, ZHOU, Jinglan, 50 Northern Avenue
Boston MA 02210, US | Fuldmægtig | | Interessent på tilknyttet sag | | IPC-Klasse | A61K 31/44 (2006.01) , A61P 11/00 (2006.01) , C07D 213/82 (2006.01) , C07D 401/14 (2006.01) | Titel/benævnelse | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Internationalt ansøgningsnr. | US2017025381 | Internationalt publ. nr. | WO2017173274 | Relateret sag (certifikat) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|